Who inspires you through cancer?
Read More
Drug Approved to Treat Pre-Cancer
Picato OK'ed to treat precancerous skin lesions.
News from ASCO: Prostate and Colorectal Cancers
Updates from the American Society of Clinical Oncology meetings on genitourinary and gastrointestinal cancers.
ASCO Updates: New Treatments on the Horizon in Prostate Cancer
Research was presented at the ASCO Genitourinary Cancers Symposium, including advancements in prostate cancer.
Rare Disease Day
Want to get back to work after cancer? Here's help
Why regulation matters ... but also flexibility
Making every breath matter
Multitasking Drug Emerges for Patients with Metastatic Colorectal Cancer
Regorafenib shows to extend survival in metastatic colorectal cancer.
Make a difference
After a dry spell, metastatic prostate cancer sees dramatic improvement with new therapies
A 'gutsy' phase 3 clinical trial in colorectal cancer
A call for more pancreatic cancer research
GA101 Could Upstage Rituxan in Lymphoma
GA101 could be the next step for patients who relapse on Rituxan (rituximab), a current standard of therapy.
Investigational Drug Shows Benefit in CLL
In an early-phase study, PCI-32765, a BTK inhibitor, was shown to work against CLL, a type of non-Hodgkin lymphoma.
No Need for Maintenance Rituxan in Asymptomatic Follicular Lymphoma
Patients who are not suffering from symptoms of nonbulky follicular lymphoma are better off waiting until symptoms occur before beginning chemotherapy instead of undergoing maintenance Rituxan.
Ponatinib Overcomes Tricky Mutation in CML
A novel drug called ponatinib that targets the BCR-ABL mutation overcomes a mutation that has been resistant to all previous approved therapies.
Different Dosing Schedule May Revive Withdrawn Drug
A drug removed from the market last year to treat acute myeloid leukemia may have a second life.
Lymphoma Drug Adcetris Tested in Newly Diagnosed Patients
With the approval of Adcetris (brentuximab vedotin) for relapsed Hodgkin lymphoma, researchers are now examining whether the drug will help newly diagnosed patients.
The big news from the American Society of Hematology
Research Updates
Research updates from the annual San Antonio Breast Cancer Symposium and American Society of Hematology.
IHadCancer.com
IHadCancer.com is a social networking site for those affected by cancer.
Aspirin Delivers on Colorectal Cancer Prevention
A new study published in The Lancet shows that one group could reduce their risk of colorectal cancer from taking the pill on a daily basis.
Afinitor Impresses in Advanced Breast Cancer
Afinitor (exemestane) and an aromatase inhibitor delay cancer growth in metastatic breast cancer.
Novel Hormone Therapy Combination Shown to Prolong Survival
A phase 3 randomized trial of two hormone therapies showed that in some postmenopausal women with hormone-positive metastatic breast cancer, the combo improves survival.
Zometa’s Survival Benefit Confirmed
Women receiving a supportive care drug to reduce bone loss caused by breast cancer treatment may actually be getting more than that—improved survival and lower risk of metastatic recurrence.
Afinitor impresses in advanced hormone-positive breast cancers
Blogroll for San Antonio's breast cancer meeting
Breast Cancer and the Environment Report offers research roadmap
Saving your oocytes